GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (TSXV:ZYUS) » Definitions » Pretax Margin %

ZYUS Life Sciences (TSXV:ZYUS) Pretax Margin % : -2,942.98% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ZYUS Life Sciences Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. ZYUS Life Sciences's Pre-Tax Income for the three months ended in Mar. 2024 was C$-3.36 Mil. ZYUS Life Sciences's Revenue for the three months ended in Mar. 2024 was C$0.11 Mil. Therefore, ZYUS Life Sciences's pretax margin for the quarter that ended in Mar. 2024 was -2,942.98%.

The historical rank and industry rank for ZYUS Life Sciences's Pretax Margin % or its related term are showing as below:

TSXV:ZYUS' s Pretax Margin % Range Over the Past 10 Years
Min: -13800.28   Med: -11387.44   Max: -8293.62
Current: -12878.3


TSXV:ZYUS's Pretax Margin % is ranked worse than
98.63% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 4.06 vs TSXV:ZYUS: -12878.30

ZYUS Life Sciences Pretax Margin % Historical Data

The historical data trend for ZYUS Life Sciences's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZYUS Life Sciences Pretax Margin % Chart

ZYUS Life Sciences Annual Data
Trend Dec21 Dec22 Dec23
Pretax Margin %
-11,387.44 -8,293.62 -13,800.28

ZYUS Life Sciences Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -6,220.51 -15,577.92 -4,256.57 -31,211.34 -2,942.98

Competitive Comparison of ZYUS Life Sciences's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, ZYUS Life Sciences's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ZYUS Life Sciences's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ZYUS Life Sciences's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where ZYUS Life Sciences's Pretax Margin % falls into.



ZYUS Life Sciences Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

ZYUS Life Sciences's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-48.439/0.351
=-13,800.28 %

ZYUS Life Sciences's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-3.355/0.114
=-2,942.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ZYUS Life Sciences  (TSXV:ZYUS) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


ZYUS Life Sciences Pretax Margin % Related Terms

Thank you for viewing the detailed overview of ZYUS Life Sciences's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


ZYUS Life Sciences (TSXV:ZYUS) Business Description

Traded in Other Exchanges
Address
407 Downey Road, Unit 204, Saskatoon, SK, CAN, S7N 4L8
ZYUS Life Sciences Corp is a next-generation life sciences company engaged in scientific research and development in phyto-therapeutics, including cannabinoid and protein-based formulations. It is committed to delivering high-quality standardized therapeutic formulations that comply with Good Manufacturing Practices (GMP) to provide targeted relief for patients in Canada and globally.
Executives
John Michael Hyshka Senior Officer

ZYUS Life Sciences (TSXV:ZYUS) Headlines

No Headlines